Page 166 - Overactive Bladder News Today

0 another look at our breaking news in oakland, where fire burned at least two homes along interstate 5 80 at 35th avenue, and well have the latest on abc, seven years at four. tonight several developing stories as we come on the air. tropical storm fiona taking aim at puerto rico in the coming hours. with the forecast models now say about the eastern u. s. and its thousands more in queen elizabeth. there has been word of a disturbance tonight at westminster officers moving in and word of an arr...

Data Bridge Market research has recently published comprehensive business research on "Global Underactive Bladder Market" including historic data, present

The increase in the number of R&D programs, and the rise in public-private partnerships for facilitating novel developments for innovative and effective...

Interim 12-week analysis from the ongoing Phase 2a trial of an investigational novel gene therapy product, URO-902 (plasmid human cDNA encoding maxi-K channel), receives International Continence

Urovant Sciences, Inc. receives Fortuneand Great Place to Work Best Workplaces in BioPharma (2022) recognition. Follows Urovant's Best Place to Work recognition by the Orange County Business

Overactive bladder (OAB) is a clinical syndrome defined by urinary urgency, increased daytime urinary frequency and/or nocturia, with or without urinary incontinence, that affects approximately 11% of the western population. OAB is accepted as an idiopathic disorder, and is charactersied clinically in the absence of other organic diseases, including urinary tract infection. Despite this, a growing body of research provides evidence that a significant proportion of OAB patients have active bladde...

The Business Research Company’s Genito-Urinary Drugs Global Market Report 2022: Market Size, Trends, And Forecast To 2026

Rx to OTC Switch market is expected to increase 1.5X times during the forecast period of 2022 to 2030.

Survey of 71 Directors of Nursing (DONs) highlights a need for improved awareness, education, and management of urinary incontinence (UI) related to overactive bladder (OAB) in long-term care (LTC)

Key Companies Covered in the Global Gene Therapy Market by Kenneth Research are Kineta, Inc., Novartis AG, Amgen Inc., bluebird bio, Inc., Gilead Sciences,...